Follow-up recommendations for colon cancer

Clinics in Colon and Rectal Surgery

Volumn 18, Issue 3, 2005, Pages 232-243

  Buie, W Donald ^a,b   Attard, Jo Anne P ^b  

^a FOOTHILLS HOSPITAL   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Colorectal neoplasm; Follow up; Neoplasm metastasis diagnosis; Neoplasm recurrence detection; Surveillance; Survival

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ANTIGEN DETECTION; CANCER DIAGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLON CANCER; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; HUMAN; IMAGING; METASTASIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; REVIEW; RISK ASSESSMENT;

EID: 24344443256     PISSN: 15310043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-916284     Document Type: Review

References (78)

1. 232-243 1. Bohm B, Schwenk W, Hucke HP, et al. Does methodic long-term follow-up affect survival after curative resection of colorectal carcinoma? Dis Colon Rectum 1993;36:280-286
2. Falterman KW, Hill CB, Markey JC, et al. Cancer of the colon, rectum, and anus: a review of 2313 cases. Cancer 1974;34:suppl 951-9
3. Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-358
4. Olson RM, Perencevich NP, Malcolm AW, et al. Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum. Cancer 1980;45:2969-2974
5. Pestana C, Reitemeier RJ, Moertel CG, et al. The natural history of carcinoma of the colon and rectum. Am J Surg 1964;108:826-829
6. Safi F, Beyer HG. The value of follow-up after curative surgery of colorectal carcinoma. Cancer Detect Prev 1993;17:417-424
7. Goldberg RM, Fleming TR, Tangen CM, et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 1998;129:27-35
8. Scholefield JH, Steele RJ. Guidelines for follow up after resection of colorectal cancer. Gut 2002;51(suppl 5):V3-V5
9. Ohlsson B, Breland U, Ekberg H, et al. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum 1995;38:619-626
10. Deveney KE, Way LW. Follow-up of patients with colorectal cancer. Am J Surg 1984;148:717-722
11. Sugarbaker PH, Gianola FJ, Dwyer A, et al. A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results. Surgery 1987;102:79-87
12. Meyerhardt JA, Mayer RJ. Follow-up strategies after curative resection of colorectal cancer. Semin Oncol 2003;30:349-360
13. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 1986;100:278-284
14. Ballantyne GH, Quin J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 1993;71:4252-4266
15. McAfee MK, Allen MS, Trastek VF, et al. Colorectal lung metastases: results of surgical excision. Ann Thorac Surg 1992;53:780-785
16. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938-946
17. Steele G Jr. Standard postoperative monitoring of patients after primary resection of colon and rectum cancer. Cancer 1993;71:4225-4235
18. Pietra N, Sarli L, Costi R, et al. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Dis Colon Rectum 1998;41:1127-1133
19. Secco GB, Fardelli R, Gianquinto D, et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 2002;28:418-423
20. Renehan AG, Egger M, Saunders MP, et al. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 2002;324:813
21. Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2002;1. art. no. CD002200 DOI 10.1002/14651858-1-26
22. Tornqvist A, Ekelund G, Leandoer L. Early diagnosis of metachronous colorectal carcinoma. Aust NZJ Surg 1981;51:442-445
23. Heald RJ, Lockhart-Mummery HE. The lesion of the second cancer of the large bowel. Br J Surg 1972;59:16-19
24. McArdle C. ABC of colorectal cancer: effectiveness of follow up. BMJ 2000;321:1332-1335
25. Anthony T, Simmang C, Hyman N, et al. Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer. Dis Colon Rectum 2004;47:807-817
26. Stiggelbout AM, de Haes JC, Vree R, et al. Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer 1997;75:914-920
27. Kiebert GM, Welvaart K, Kievit J. Psychological effects of routine follow up on cancer patients after surgery. Eur J Surg 1993;159:601-607
28. Kjeldsen BJ, Thorsen H, Whalley D, et al. Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scand J Gastroenterol 1999;34:509-515
29. Hennekens C, Buring J. Epidemiology in Medicine. Philadelphia: Lippincott Williams & Wilkins; 1987:327-347
30. Phillips RK, Hittinger R, Blesovsky L, et al. Large bowel cancer: surgical pathology and its relationship to survival. Br J Surg 1984;71:604-610
31. Finlay IG, McArdle CS. Occult hepatic metastases in colorectal carcinoma. Br J Surg 1986;73:732-735
32. Figueredo A, Rumble RB, Maroun J, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer 2003;3:26
33. Gordis L. Epidemiology. 2nd ed, Philadelphia: WB Saunders; 2000:60-70
34. Wein A, Riedel C, Bruckl W, et al. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer. Oncology 2003;64:131-138
35. Pozzo C, Basso M, Cassano A, et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol 2004;15:933-939
36. Johnson FE, Virgo KS, Fossati R. Follow-up for patients with colorectal cancer after curative-intent primary treatment. J Clin Oncol 2004;22:1363-1365
37. Vernava AM III, Longo WE, Virgo KS, et al. Current follow-up strategies after resection of colon cancer. Results of a survey of members of the American Society of Colon and Rectal Surgeons. Dis Colon Rectum 1994;37:573-583
38. Kjeldsen BJ, Kronborg O, Fenger C, et al. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg 1997;84:666-669
39. Mäkelä JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 1995;130:1062-1067
40. Schoemaker D, Black R, Giles L, et al. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 1998;114:7-14
41. Staib L, Link KH, Beger HG. Follow-up in colorectal cancer: cost-effectiveness analysis of established and novel concepts. Langenbecks Arch Surg 2000;385:412-420
42. Desch CE, Benson AB III, Smith TJ, et al. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. J. Clin Oncol 1999;17:1312
43. Fleischer DE, Goldberg SB, Browning TH, et al. Detection and surveillance of colorectal cancer. JAMA 1989;261:580-585
44. Engstrom PF, Benson AB III, Cohen A, et al. NCCN Colorectal Cancer Practice Guidelines. The National Comprehensive Cancer Network. Oncology (Williston Park) 1996;10(11 suppl):140-175
45. Practice NCCN. Guidelines in Oncology-v2. 2005. Colon Cancer. www.nccn.org/professionals/physicians_gls/ PDF/colon.pdf
46. Fantini GA, DeCosse JJ. Surveillance strategies after resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 1990;171:267-273
47. Galandiuk S, Wieand HS, Moertel CG, et al. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 1992;174:27-32
48. Mäkelä J, Haukipuro K, Laitinen S, et al. Surgical treatment of recurrent colorectal cancer. Five-year follow-up. Arch Surg 1989;124:1029-1032
49. Ovaska J, Jarvinen H, Kujari H, et al. Follow-up of patients operated on for colorectal carcinoma. Am J Surg 1990;159:593-596
50. Tornqvist A, Ekelund G, Leandoer L. The value of intensive follow-up after curative resection for colorectal carcinoma. Br J Surg 1982;69:725-728
51. Richard CS, McLeod RS. Follow-up of patients after resection for colorectal cancer: a position paper of the Canadian Society of Surgical Oncology and the Canadian Society of Colon and Rectal Surgeons. Can J Surg 1997;40:90-100
52. Graffner H, Hultberg B, Johansson B, et al. Detection of recurrent cancer of the colon and rectum. J Surg Oncol 1985;28:156-159
53. Graham RA, Wang S, Catalano PJ, et al. Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy. Ann Surg 1998;228:59-63
54. McCall JL, Black RB, Rich CA, et al. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum 1994;37:875-881
55. Moertel CG, Fleming TR, Macdonald JS, et al. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993;270:943-947
56. Fletcher RH. Carcinoembryonic antigen. Ann Intern Med 1986;104:66-73
57. Goslin R, Steele G Jr, Macintyre J, et al. The use of preoperative plasma CEA levels for the stratification of patients after curative resection of colorectal cancers. Ann Surg 1980;192:747-751
58. Fucini C, Tommasi SM, Rosi S, et al. Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, Ca 19-9 analysis and second-look surgery. Dis Colon Rectum 1987;30:273-277
59. Martin EW Jr, Cooperman M, Carey LC, et al. Sixty second-look procedures indicated primarily by rise in serial carcinoembryonic antigen. J Surg Res 1980;28:389-394
60. Goya T, Miyazawa N, Kondo H, et al. Surgical resection of pulmonary metastases from colorectal cancer. 10-year follow-up. Cancer 1989;64:1418-1421
61. McCormack PM, Attiyeh FF. Resected pulmonary metastases from colorectal cancer. Dis Colon Rectum 1979;22:553-556
62. Smith TJ, Bear HD. Standard follow-up of colorectal cancer patients: finally, we can make practice guidelines based on evidence. Gastroenterology 1998;114:211-213
63. Chau I, Allen MJ, Cunningham D, et al. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. J Clin Oncol 2004;22:1420-1429
64. Adam R, Avisar E, Ariche A, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 2001;8:347-353
65. Giacchetti S, Itzhaki M, Gruia G, et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999;10:663-669
66. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003;124:544-560
67. Anthony T, Fleming JB, Bieligk SC, et al. Postoperative colorectal cancer surveillance. J Am Coll Surg 2000;190:737-749
68. Cali RL, Pitsch RM, Thorson AG, et al. Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum 1993;36:388-393
69. Green RJ, Metlay JP, Propert K, et al. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089. Ann Intern Med 2002;136:261-269
70. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329:1977-1981
71. Norum J, Olsen JA. A cost-effectiveness approach to the Norwegian follow-up programme in colorectal cancer. Ann Oncol 1997;8:1081-1087
72. Liberati A, Torri V, Apolone G. Assessing the effectiveness of follow-up care for colorectal cancer: a great conceptual and methodological challenge for clinical oncology. Ann Oncol 1997;8:1059-1062
73. Borie F, Combescure C, Daures JP, et al. Cost-effectiveness of two follow-up strategies for curative resection of colorectal cancer: comparative study using a Markov model. World J Surg 2004;28:563-569
74. Virgo KS, Vernava AM, Longo WE, et al. Cost of patient follow-up after potentially curative colorectal cancer treatment. JAMA 1995;273:1837-1841
75. Bruinvels DJ, Stiggelbout AM, Kievit J, et al. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg 1994;219:174-182
76. Renehan AG, O'Dwyer ST, Whynes DK. Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer. BMJ 2004;328:81
77. Kraemer M, Wiratkapun S, Seow-Choen F, et al. Stratifying risk factors for follow-up: a comparison of recurrent and nonrecurrent colorectal cancer. Dis Colon Rectum 2001;44:815-821
78. ESMO Minimum Clinical Recommendations. 2002. www. esmo.org/reference/ reference_guidelines.htm